Phosphorylation of myosin light chain at distinct sites and its association with the cytoskeleton during enteropathogenic Escherichia coli infection.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 43 citations in OpenAlex.

1. Modulation of Intestinal Paracellular Transport by Bacterial Pathogens.Comprehensive Physiology · 2018
   Review
2. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection.World journal of gastroenterology · 2014
   Review
3. Chlamydia trachomatis inclusion membrane protein CT228 recruits elements of the myosin phosphatase pathway to regulate release mechanisms.Cell reports · 2013
   Article
4. Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.Annals of the New York Academy of Sciences · 2012
   Review
5. Infectious diarrhea: Cellular and molecular mechanisms.Gut microbes · 2010
   Article
6. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.Infection and immunity · 2005
   Review
7. Modulation of myosin light-chain phosphorylation by p21-activated kinase 1 in Escherichia coli invasion of human brain microvascular endothelial cells.Infection and immunity · 2003
   Article
8. Enteropathogenic Escherichia coli activates ezrin, which participates in disruption of tight junction barrier function.Infection and immunity · 2001
   Article
9. MLCK-A, an unconventional myosin light chain kinase from Dictyostelium, is activated by a cGMP-dependent pathway.Proceedings of the National Academy of Sciences of the United States of America · 1998
   Article
10. Increased levels of intracellular calcium are not required for the formation of attaching and effacing lesions by enteropathogenic and enterohemorrhagic Escherichia coli.Infection and immunity · 1998
    Article
11. Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability.Infection and immunity · 1998
    Article
12. Diarrheagenic Escherichia coli.Clinical microbiology reviews · 1998
    Review
13. A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells.Infection and immunity · 1997
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as